BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
66.62
+0.67 (1.02%)
May 13, 2026, 10:39 AM EDT - Market open
BridgeBio Pharma Analyst Ratings
Total Analysts
25
Consensus Rating
Strong Buy
Price Target
$86.96
Upside
+30.53%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +65.12% | May 11, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $125 → $130 | Buy | Maintains | $125 → $130 | +95.14% | May 8, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $95 → $102 | Strong Buy | Maintains | $95 → $102 | +53.11% | Apr 29, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +50.11% | Apr 29, 2026 |
| Mizuho | Mizuho | Buy Reiterates $106 | Buy | Reiterates | $106 | +59.11% | Apr 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +50.11% | Apr 27, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $100 | Buy | Initiates | $100 | +50.11% | Apr 9, 2026 |
| Mizuho | Mizuho | Buy Maintains $91 → $106 | Buy | Maintains | $91 → $106 | +59.11% | Mar 18, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $89 → $94 | Buy | Maintains | $89 → $94 | +41.10% | Mar 10, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 10, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $86 → $95 | Strong Buy | Maintains | $86 → $95 | +42.60% | Feb 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $83 → $81 | Buy | Maintains | $83 → $81 | +21.59% | Feb 25, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $96 → $98 | Buy | Maintains | $96 → $98 | +47.10% | Feb 25, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $100 → $125 | Buy | Maintains | $100 → $125 | +87.63% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $100 | Strong Buy | Maintains | $90 → $100 | +50.11% | Feb 17, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $81 → $83 | Buy | Maintains | $81 → $83 | +24.59% | Feb 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.